Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TBPH | Ordinary Shares | Tax liability | -$11.3K | -1.35K | -0.8% | $8.36 | 167K | Nov 19, 2021 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
F2 | Includes 1228 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on November 15, 2021. |